Sliutz, G., Karlseder, J., Tempfer, C., Orel, L., Holzer, G. and Simon, M.M. (1996) Drug Resistance against Gemcitabine and Topotecan Mediated by Constitutive hsp70 Overexpression in Vitro: Implication of Quercetin as Sensitiser in Chemotherapy. British Journal of Cancer, 74, 172-177.
http://dx.doi.org/10.1038/bjc.1996.334

has been cited by the following article:

• TITLE: Quercetin: A Promising Flavonoid with a Dynamic Ability to Treat Various Diseases, Infections, and Cancers

  AUTHORS: Aaron J. Smith, John Oertle, Dan Warren, Dino Prato

  KEYWORDS: Quercetin, Cancer, Infection, Biomarkers, Diabetes, Mast Cell, Cardiovascular

  JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.2, February 22, 2016

  ABSTRACT: Quercetin is a multifaceted dietary flavonoid with a multitude of biologic activities that can be used to treat various ailments. These include cancer, bacterial and viral infections, cardiovascular disease, and diabetes. A greater emphasis on cancer is discussed within this paper by highlighting some of the beneficial qualities of quercetin without including other related dietary flavonoids and quercetin analogs. In vitro and in vivo analysis are evaluated without making recommendations on dosage, dosing regiments, or administration since quercetin has not been subjected to rigorous clinical trials despite the significant amount of research that has been conducted with quercetin.